Home-Based Hybrid Closed-Loop Setup Trial: Evaluating Safety and Cost-Effectiveness in Type 1 Diabetes Management

References

1. 1.Air Liquide Healthcare Spain. (2024). Safety, effectiveness, quality of life, costs, and efficiency of the home setup of the hybrid closed-loop system in people with type 1 diabetes: Application of a value-based diabetes management model. ClinicalTrials.gov. NCT07492992. https://clinicaltrials.gov/study/NCT07492992
2. 2.Australian Institute of Health and Welfare. (2023). Diabetes in Australia. AIHW. https://www.aihw.gov.au/reports/diabetes/diabetes-in-australia
3. 3.Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., Cobelli, C., Dassau, E., DeVries, J. H., Donaghue, K. C., Dovc, K., Doyle, F. J., Garg, S., Grunberger, G., Heller, S., ... Phillip, M. (2019). Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care, 42(8), 1593-1603. https://doi.org/10.2337/dci19-0028
4. 4.Bekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A. B., Hovorka, R., & Tsapas, A. (2018). Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis. BMJ, 361, k1310. https://doi.org/10.1136/bmj.k1310
5. 5.Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Palerm, C. C., Slover, R. H., Anderson, S. M., Bergenstal, R. M., Breton, M. D., Chernavvsky, D. R., Criego, A. B., Demissie, M., Desalvo, D. J., Doss, A., Doyle, F. J., ... Wadwa, R. P. (2019). Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. New England Journal of Medicine, 381(18), 1707-1717. https://doi.org/10.1056/NEJMoa1907863